Enanta Pharmaceuticals, Inc.
ENTA
$11.37
$0.020.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 163.77M | 185.85M | 188.86M | 204.11M | 193.38M |
| Total Receivables | 7.83M | 8.49M | 6.88M | 8.36M | 40.63M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.81M | 4.34M | 8.59M | 10.24M | 8.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 178.41M | 198.68M | 204.34M | 222.71M | 242.86M |
|
|
|||||
| Total Current Assets | 178.41M | 198.68M | 204.34M | 222.71M | 242.86M |
| Net Property, Plant & Equipment | 69.55M | 71.31M | 72.94M | 74.87M | 76.68M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.50M | 3.45M | 3.45M | 3.45M | 3.46M |
| Total Assets | 314.70M | 329.50M | 280.73M | 301.03M | 322.99M |
|
|
|||||
| Total Accounts Payable | 4.36M | 1.89M | 1.95M | 3.55M | 4.76M |
| Total Accrued Expenses | 6.86M | 7.58M | 12.75M | 10.85M | 8.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.22M | 35.27M | 33.86M | 30.15M | 32.88M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 46.44M | 44.73M | 48.56M | 44.55M | 45.95M |
|
|
|||||
| Total Current Liabilities | 46.44M | 44.73M | 48.56M | 44.55M | 45.95M |
| Long-Term Debt | 98.62M | 104.13M | 112.44M | 121.29M | 126.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 52.78M | 53.78M | 54.76M | 55.66M | 56.54M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 278.00K | 269.00K | 260.00K | 252.00K | 243.00K |
| Total Liabilities | 198.12M | 202.91M | 216.02M | 221.75M | 229.46M |
|
|
|||||
| Common Stock & APIC | 547.28M | 543.79M | 469.99M | 465.91M | 461.74M |
| Retained Earnings | -429.96M | -416.87M | -404.93M | -386.23M | -367.97M |
| Treasury Stock & Other | -734.00K | -329.00K | -339.00K | -402.00K | -224.00K |
| Total Common Equity | 116.59M | 126.59M | 64.72M | 79.28M | 93.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 116.59M | 126.59M | 64.72M | 79.28M | 93.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 116.59M | 126.59M | 64.72M | 79.28M | 93.54M |
|
|
|||||